Researchers say they have successfully grown functional kidneys inside rats using just a few donor stem cells, an advance with significant implications for human organ transplantation.
For patients with end-stage renal disease, a kidney transplant is the only hope for regaining quality of life, according to the study published in the journal Nature Communications.
Yet many of these patients will never undergo transplant surgery due to a chronic shortage of donor kidneys, said researchers from the National Institute for Physiological Sciences in Japan.
With 95,000 patients on the waiting list for a donor kidney in the US alone, demand far outstrips supply, they said.
However, researchers have been working on ways to grow healthy organs outside the human body.
One such method, called blastocyst complementation, has already produced promising results.
Researchers take blastocysts, the clusters of cells formed several days after egg fertilisation, from mutant animals missing specific organs and inject them with stem cells from a normal donor, not necessarily of the same species.
The stem cells then differentiate to form the entire missing organ in the resulting animal.
The new organ retains the characteristics of the original stem cell donor, and can thus potentially be used in transplantation therapy.
"We previously used blastocyst complementation to generate rat pancreas in a pancreatic mutant mice," said Teppei Goto, the lead author of the study.
"We therefore decided to investigate whether the method could be used to generate functional kidneys, which would have much greater application in regenerative medicine owing to the high donor demand," Goto said.
Initial attempts by the researchers to grow rat kidneys in mice proved unsuccessful, as rat stem cells did not readily differentiate into the two main types of cells needed for kidney formation.
However, when the reverse scenario was attempted, mouse stem cells efficiently differentiated inside rat blastocysts, forming the basic structures of a kidney.
After being implanted into pseudo-pregnant rats, the complemented blastocysts matured into normal fetuses, researchers said.
More than two thirds of the resulting rat neonates contained a pair of kidneys derived from the mouse stem cells.
Further screening showed that all of the kidneys were structurally intact, and at least half could potentially produce urine.
"Our findings confirm that interspecific blastocyst complementation is a viable method for kidney generation," said study corresponding author Masumi Hirabayashi.
"In the future, this approach could be used to generate human stem cell-derived organs in livestock, potentially extending the lifespan and improving the quality of life of millions of people worldwide," said Hirabayashi.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
